PitchBook：2024年三季度制药技术报告（英文版）

The pace of VC deals in the pharmatech sector picked up with 65 deals completed in Q3 compared with 47 in Q2, despite a dip to $1.1 billion invested in total.The sector is propelled forward by technologies that work to enhance precision, scalability, and speed across pharmaceutical and biotech research, manufacturing, and development. Our latest Emerging Tech Research outlines DNA synthesis services and cell-free manufacturing as key innovation opportunities, with spotlights on VC-backed comp